Prostate Cancer
📧 Sign up to get email alerts when something new happens for Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-27Clinical Trial Update: EBRT and HDR Brachytherapy for Unfavorable-intermediate, High, and Very High-risk Prostate Cancer [Phase 2]
Phase 2 trial evaluating external beam radiotherapy and high-dose-rate brachytherapy for unfavorable-intermediate, high, and very high-risk …
-
CLINICAL_TRIALS trial_result · 2026-04-24Clinical Trial Update: Study of Abiraterone Acetate or Enzalutamide, Atezolizumab, GnRH Analog and Radiation Therapy in Men With Newly Diagnosed Hormone-sensitive Prostate Cancer [Phase 2]
Phase 2 study evaluating a multi-drug regimen combining either Abiraterone Acetate or Enzalutamide with Atezolizumab, a GnRH analog, and rad…
-
CLINICAL_TRIALS trial_result · 2026-04-24Clinical Trial Update: Focal Laser Ablation of Prostate Cancer [EARLY_Phase 1]
Clinical trial update indicating the completion of an early-phase study evaluating focal laser ablation as a treatment for prostate cancer.
-
CLINICAL_TRIALS trial_result · 2026-04-24Clinical Trial Update: Neoadjuvant Androgen Deprivation Therapy Combined With Enzalutamide and Abiraterone Using Multiparametric MRI and 18FDCFPyL PET/CT in Newly Diagnosed Prostate Cancer [Phase 2]
Phase 2 neoadjuvant trial in newly diagnosed castration-sensitive prostate cancer evaluating combination therapy with enzalutamide and abira…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: PSMA-High: EBRT/ PSMA617/ ADT vs. EBRT/ ADT [Phase 2]
A Phase 2 trial at Johns Hopkins is evaluating adding PSMA617 to standard external beam radiotherapy and androgen deprivation therapy for hi…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Integrated Genomic Prostate Score With MRI Targeted Prostate Biopsies
A National Cancer Institute–sponsored clinical trial is evaluating the Integrated Genomic Prostate Score in combination with MRI-targeted pr…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Low Dose Naltrexone (LDN) for Management of Fatigue in Prostate Cancer Patients on Androgen Deprivation Therapy (ADT) [Phase 2]
Phase 2 clinical trial evaluating low-dose naltrexone for fatigue management in metastatic prostate cancer patients on androgen deprivation …
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Working Out M0 Bipolar Androgen Therapy [Phase 2]
Phase 2 clinical trial investigating M0 Bipolar Androgen Therapy for prostate cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Profiling of Radiological Factors in Treatment and Outcomes in Prostate Cancer
This clinical trial update describes profiling radiological factors to evaluate treatment outcomes in prostate cancer. Recruitment is curren…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Natural History Study of Early Life Exposures in Agriculture (ELEA)
An update on the ELEA natural history study sponsored by the National Cancer Institute investigating how early life exposures in agriculture…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Prospective Monitoring of Subjects With Biochemically Recurrent Prostate Cancer Using 18FDCFPyL
Clinical trial update showing that 18F-DCFPyL is being used to prospectively monitor subjects with biochemically recurrent prostate cancer a…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Prostate Specific Membrane Antigen (PMSA)-Based PET Imaging of High Risk Prostate Cancer [Phase 2]
A Phase 2 clinical trial is evaluating PSMA-based PET imaging for high-risk prostate cancer, and the study is currently active but not recru…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Collection of Blood From Patients With Prostate Cancer
A clinical trial update indicates that recruitment is ongoing to collect blood from patients with prostate cancer.
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Focal Therapy With Stereotactic Body Radiation Therapy (SBRT) for Patients With a Single Prostate Tumor [Phase 2]
Phase 2 clinical trial evaluating focal therapy with stereotactic body radiation therapy (SBRT) for a single prostate tumor; the study is cu…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: PROSTATE-IQ: Parallel RandOmized STudy of Personalized Apalutamide Treatment and Evaluation to Improve Quality of Life in Post-Operative Radiation With Androgen Axis Suppression. A Phase III Multi-center Study for Men With Detectable PSA After Prostatectomy for Prostate Cancer. [Phase 3]
Phase III multicenter trial evaluating personalized apalutamide with post-operative radiation and androgen axis suppression for men with det…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Proton Therapy vs. IMRT for Low or Intermediate Risk Prostate Cancer [NA]
ClinicalTrials.gov entry describing a trial comparing proton therapy versus IMRT for low- or intermediate-risk prostate cancer. The study is…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Precision-Based Genomics in Prostate Cancer
A National Cancer Institute-sponsored clinical trial exploring precision-based genomic approaches in prostate cancer is currently recruiting…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: A Study of DXC014 in Patients With Advanced Solid Tumors. [Phase 1]
Phase 1 study of the investigational drug DXC014 in advanced solid tumors is currently recruiting. It includes patients with small cell lung…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: High-Risk prostatE Cancer radiatiOn Versus surgERy
A clinical trial in the Netherlands is recruiting to compare radiotherapy versus surgery for high-risk prostate cancer.
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: AI Algorithm-Informed Biopsy for Prostate Cancer Detection With Indeterminate and Low-Risk Prostate MRI Lesions [NA]
A planned University of Arkansas clinical trial evaluates an AI-informed biopsy approach to detect prostate cancer in men with indeterminate…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: A Study of GSK5458514 Administered Alone or In Combination With Other Anti-Cancer Agents in Participants With Prostate Cancer [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating GSK5458514 alone or in combination with other anti-cancer agents in prostate cancer is currently recru…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: DS3201 and Ipilimumab for the Treatment of Metastatic Prostate, Urothelial and Renal Cell Cancers [Phase 1]
Phase 1 clinical trial update evaluating DS3201 in combination with ipilimumab for metastatic prostate, urothelial, and renal cell cancers.
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Imaging Studies to Check the Local Response of Prostate Cancer to Radiation Therapy
This ClinicalTrials.gov entry describes imaging studies used to assess the local response of prostate cancer to radiation therapy in an ongo…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: A Study of Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone Acetate [Phase 2]
A Phase 2 trial is evaluating talazoparib with or without enzalutamide in men with prostate cancer who have previously received abiraterone …
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Open-Label Study of Pocenbrodib Alone and in Combination With Abiraterone Acetate, Olaparib, or 177Lu-PSMA-617 [Phase 1, Phase 2]
Open-label Phase 1/2 trial of Pocenbrodib alone and in combination with Abiraterone acetate, Olaparib, or 177Lu-PSMA-617 is currently recrui…